The treatment of osteosarcoma in 1992
β Scribed by S. R. Babin; A. Babin-Boilletot
- Publisher
- Springer
- Year
- 1992
- Tongue
- English
- Weight
- 174 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1432-1068
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background Cisplatin (cDDP), when used either alone or, more often, in combination with other agents, especially adriamycin, achieves a high response rate in osteosarcoma. Its use, however, is limited by severe nephroβ and neuroβtoxicity. Second generation platinum compounds, most n
## Abstract ## BACKGROUND: This study evaluated the safety and feasibility of the addition of pamidronate to chemotherapy for treatment of osteosarcoma. ## METHODS: The authors treated 40 patients with osteosarcoma with cisplatin, doxorubicin, and methotrexate with the addition of pamidronate 2
## Abstract ## Background Unplanned primary surgery has been known to have a negative prognostic impact in osteosarcoma. ## Methods We identified 20 osteosarcoma patients that had undergone inadvertent surgery followed by adequate treatment without delay, and compared the clinicopathologic chara